Here’s an overview of six stocks, including their exchange, recent performance, and a brief description. This post is for information and personal discovery purposes. It is not an indicator to buy, sell, or hold to any of these stocks. Stock prices are volatile and subject to rapid changes. It’s advisable to consult financial advisors or use real-time trading platforms for the most current information. The stock performance summaries are based on general trends observed over the past ten trading days and are not indicative of future results.
Exchange: NYSE
Recent Performance: HAE has held steady over the past ten trading days, fluctuating modestly around the low‑$70s.
Description: Haemonetics supplies medical technologies for blood and plasma management, surgical safety, and hospital transfusion services . It recently reported Q1 2025 revenue of $330.6 million, slightly behind year‑ago levels, but maintains a positive analyst outlook.
Sector: Healthcare / Medical Devices
Exchange: NASDAQ
Recent Performance: NKTR shot up over 115% in premarket and doubled intraday after strong Phase 2b eczema trial data .
Description: Nektar develops immunotherapy drugs, with its lead candidate rezpegaldesleukin showing 53–61% symptom improvement in atopic dermatitis versus 31% for placebo .
Sector: Healthcare / Biopharmaceuticals
Vicarious Surgical Inc. (RBOT)
Exchange: NYSE
Recent Performance: VCSA has seen mild volatility over the past ten days amid updates on its Q1 losses and partnership news.
Description: Vicarious Surgical is developing surgeon-in‑head robotic systems for minimally invasive surgery, working on a beta‑2 version and FDA timeline submission by next year .
Sector: Technology / Surgical Robotics
Exchange: NASDAQ
Recent Performance: AMRN has gained ~20% over the last ten trading days as investor interest in its cardiovascular drug Vascepa grows.
Description: Amarin is a biopharma company focused on cardiovascular health; its flagship drug Vascepa (icosapent ethyl) is FDA-approved for reducing cardiovascular risk among patients with elevated triglycerides .
Sector: Healthcare / Biotechnology
Exchange: NASDAQ
Recent Performance: DUOL has given back about 6% recently after a strong YTD rally (~38%), but remains significantly above last year’s levels .
Description: Duolingo is a language-learning platform; in Q1 2025 it posted ~45% revenue growth, record profitability, and strong DAU expansion, driving improved guidance .
Sector: Consumer Services / EdTech
Exchange: NYSE
Recent Performance: YUM has climbed ~3% over the past two trading days, recently outperforming peers amid strong quarterly results .
Description: Parent of Taco Bell, KFC, and Pizza Hut, Yum posted 12% revenue growth in Q1 2025 with Taco Bell and KFC leading comps, and a new CFO-to-CEO transition set for Oct 2025 .
Sector: Consumer Discretionary / Restaurants
THIS NEWSLETTER IS PARTNERED WITH ROBINHOOD.COM AND IS FINANCIALLY SPONSORED BY THAT SERVICE.
TO BEGIN YOUR INVESTMENT JOURNEY TODAY, USE THIS LINK TO SET UP YOUR ACCOUNT.